A declaratory judgment action filed by Apotex Inc. against Forest Laboratories Inc. is pending.
On Jan. 10, 2011, Apotex Inc. filed a two-count declaratory judgment action against Forest and H. Lundbeck…
Caliper Life Sciences, Inc., and HandyLab, Inc., are discussing a potential licensing arrangement, according to the company’s Form 10-Q filing with the U.S. Securities and Exchange Commission dated Nov. 9,…
No trial date has been set for Chrimar Systems, Inc.’s patent infringement lawsuit against Foundry, according to Brocade Communications Systems, Inc.’s Form 10-Q filing with the U.S. Securities and Exchange…
Forest Laboratories Inc. and H. Lundbeck A/S face Caraco Pharmaceutical Laboratories, Ltd.’s declaratory judgment action for non-infringement of a third patent for Lexapro.
Lexapro was developed by the Company and Lundbeck,…
The patent infringement suit captioned Forest Laboratories, Inc. et al. v. Caraco Pharmaceutical Laboratories, Ltd. et al.,
remains pending in the U.S. District Court for the Eastern District of Michigan.
In September…
A trial on Caraco Pharmaceutical Laboratories, Ltd.’s action against Forest Laboratories Inc. and H. Lundbeck A/S seeking a declaratory judgment of non-infringement is scheduled to begin on Oct. 27, 2009.
In…
Lear Corp. intends to continue to defend The Chamberlain Group’s and Johnson Controls Inc.’s patent infringement suit on remand in the U.S. District Court for the Northern District of Illinois.
On…
A trial date has yet to be scheduled for Johnson Controls Inc.’s motion for reconsideration of the U.S. District Court for the Eastern District of Michigan’s ruling in Lear Corp.’s…
No dates have been set in a consultant’s arbitration action against Lear Corp. seeking royalties, according to the Company’s latest Quarterly Report on Form 10-Q filed with the U.S. Securities…
A date has not yet been set for The Chamberlain Group’s and Johnson Controls Inc.’s opposition to Lear Corp.’s motion for summary judgment in the patent infringement suit on remand…